Health
Metformin treatment linked to slowed cognitive decline – WebWire
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels. A new research study, conducted over six year…
Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimise their blood glucose levels.
A new research study, conducted over six years in the Sydney Memory and Ageing Study in 1037 Australians (aged 70 to 90 years old at baseline), has revealed an additional effect: individuals with type 2 diabetes who used metformin experienced slower cognitive decline with lower dementi…
-
Noosa News13 hours agoLogan City Council to pull out of federal government Climate Active program due to financial pressure, transparency concerns
-
General23 hours agoDarwin hosts its first Asian Cup qualifier match, deepening cultural ties between nations
-
Business14 hours agoAiming for rock-solid retirement income? I’d buy these two ASX shares
-
General23 hours agoKatie Boulter says death threats and abuse highlight dark side of tennis betting